Related Experiment Video
Updated: Jul 8, 2026

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
Cells of the synovium in rheumatoid arthritis. Macrophages
Raimund W Kinne1, Bruno Stuhlmüller, Gerd-R Burmester
1Experimental Rheumatology Unit, Department of Orthopedics, University Clinic, Jena, Klosterlausnitzer Str, 81, D-07607 Eisenberg, Germany. raimund.w.kinne@med.uni-jena.de
Abstract:
The multitude and abundance of macrophage-derived mediators in rheumatoid arthritis and their paracrine/autocrine effects identify macrophages as local and systemic amplifiers of disease. Although uncovering the etiology of rheumatoid arthritis remains the ultimate means to silence the pathogenetic process, efforts in understanding how activated macrophages influence disease have led to optimization strategies to selectively target macrophages by agents tailored to specific features of macrophage activation. This approach has two advantages: (a) striking the cell population that mediates/amplifies most of the irreversible tissue destruction and (b) sparing other cells that have no (or only marginal) effects on joint damage.
Insights
Macrophages amplify rheumatoid arthritis by releasing mediators. Targeting these activated cells offers a strategy to reduce tissue damage while sparing other cells, aiding disease management.
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Rheumatoid arthritis (RA) involves macrophage-derived mediators that amplify disease locally and systemically.
- Activated macrophages are key drivers of irreversible joint damage in RA.
Purpose of the Study:
- To explore strategies for selectively targeting activated macrophages in rheumatoid arthritis.
- To leverage understanding of macrophage activation pathways for therapeutic benefit.
Main Methods:
- Analysis of macrophage-derived mediators in rheumatoid arthritis.
- Development of targeted agents based on macrophage activation features.
Main Results:
- Macrophages act as central amplifiers of rheumatoid arthritis pathogenesis.
- Targeting activated macrophages can mitigate irreversible tissue destruction.
- Selective targeting spares other cell populations, reducing off-target effects.
Conclusions:
- Macrophages are critical targets for managing rheumatoid arthritis.
- Selective macrophage-targeting strategies offer a promising therapeutic approach for RA.
- This approach minimizes damage to non-involved cells, improving treatment safety.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction
Inflammation
Structural Joints: Synovial Joints
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...